Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2000
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000032188A3 Use of amtolmetin guacyl as an antiinflammatory drug
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2370713A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2370259A1 Pyrrolidincarbonylamino cyclic disulfides
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2367395A1 Cyclic amine derivatives and use thereof
10/26/2000CA2367367A1 (-)-verbenone derivatives
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2363689A1 Compounds useful as phosphotyrosine mimics
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045851A1 Substituted porphyrins
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271353A Furansulfonic acid derivatives and pharmaceutical compositions containing the same
10/25/2000CN1271347A 1,5-diphenylpypazole derivatives
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271284A Vitronectin receptor antagonist
10/25/2000CN1271280A A transdermal drug delivery system for anti-inflammatory analogesic agent comprising diclofenac diethylammonium, and the manufacturing method thereof
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270815A Medicated wine capable of treating several disease
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/24/2000US6136969 Azepanes
10/24/2000US6136851 Skin disorders
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136832 Racemic mixtures and enantiomorphs
10/24/2000US6136824 1-piperidinyl-propan-2-derivatives and their use as therapeutic agents
10/24/2000US6136821 Naphthyridine derivatives
10/24/2000US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/24/2000US6136817 Opioid receptor antagonist compounds
10/24/2000US6136797 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/24/2000US6136791 Viricides and anticarcinogenic agents
10/24/2000US6136790 Carbohydrate mimetics having antiadhesive properties
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136786 Analgesics produced by opiates from omega-conopeptides
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000CA2072283C Process for the preparation of diacetylrhein
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061582A1 Substituted fused imidazole derivatives
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061569A1 Adamantane derivatives
1 ... 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 ... 1272